Filter Results:
(898)
Show Results For
- All HBS Web
(1,339)
- People (4)
- News (227)
- Research (898)
- Events (4)
- Multimedia (7)
- Faculty Publications (496)
Show Results For
- All HBS Web
(1,339)
- People (4)
- News (227)
- Research (898)
- Events (4)
- Multimedia (7)
- Faculty Publications (496)
Sort by
- March 2023
- Case
Moderna
By: Marco Iansiti, Karim R. Lakhani, Hannah Mayer, Kerry Herman, Allison J. Wigen and Dave Habeeb
This multimedia case follows the story of Moderna and its entry into vaccine development in the wake of the COVID-19 pandemic. In summer 2020, Stephane Bancel, CEO of biotech firm Moderna, faces several challenges as his company races to develop a vaccine for COVID-19.... View Details
- 06 Nov 2012
- First Look
First Look: November 6
Publications The Architecture of Innovation: The Economics of Creative Organizations Author: Josh Lerner Publication: Harvard Business Press Books, 2012 Abstract Innovation is a much-used buzzword these days, but when it comes to creating and implementing a new idea,... View Details
Keywords: Sean Silverthorne
- September 2010 (Revised April 2011)
- Case
Sherritt Goes to Cuba (A): Political Risk in Unchartered Territory
By: Aldo Musacchio and Jonathan Schlefer
Ian Delaney, CEO of Sherritt, a primarily a mining company, visited Cuba in the early 1990s to negotiate a deal to export nickel for their Canadian refineries. The case describes the difficulties of doing business in Cuba and the challenges Delaney overcame to turn... View Details
Keywords: Business Conglomerates; Joint Ventures; Multinational Firms and Management; Growth and Development Strategy; Risk Management; Emerging Markets; Business and Government Relations; Mining Industry; Canada; Cuba; United States
Musacchio, Aldo, and Jonathan Schlefer. "Sherritt Goes to Cuba (A): Political Risk in Unchartered Territory." Harvard Business School Case 711-001, September 2010. (Revised April 2011.)
- 10 Apr 2014
- Research & Ideas
John Kotter’s Plan to Accelerate Your Business
that fuel this new dual system in Accelerate: Building Strategic Agility for a Faster-Moving World, released this week. The book is Kotter's latest to address large-scale organizational change. Fifteen years ago, in Leading Change, Kotter offered eight steps View Details
Keywords: by Kim Girard
- December 1999
- Case
Agrochemicals at Ciba-Geigy AG (A)
By: Michael L. Tushman, Wendy Smith and Daniel Radov
After spending five years to develop a revolutionary product, the director of Ciba-Geigy's fungicide research department is handed an unfavorable market study. The case details the R&D process for the new product, including information on corporate partnerships,... View Details
Keywords: Agribusiness; Plant-Based Agribusiness; Research and Development; Innovation and Invention; Innovation Strategy; Product Launch; Marketing Channels; Change Management; Product Development; Business Processes; Organizational Structure; Corporate Accountability; Pharmaceutical Industry; Pharmaceutical Industry
Tushman, Michael L., Wendy Smith, and Daniel Radov. "Agrochemicals at Ciba-Geigy AG (A)." Harvard Business School Case 400-022, December 1999.
- October 2010 (Revised August 2016)
- Case
On Weldon's Watch: Recalls at Johnson & Johnson from 2009 to 2010
By: Clayton S. Rose, Sandra J. Sucher, Rachel Gordon and Matthew Preble
In October of 2010, Johnson & Johnson (J&J) was unable to extricate itself from a year long recall crisis that had subjected the firm to criticism from Congress and regulators, resulted in the resignation of one of the firm's most senior officers, and cost hundreds of... View Details
Keywords: Decision Choices and Conditions; Values and Beliefs; Leadership; Crisis Management; Corporate Social Responsibility and Impact; Organizational Change and Adaptation; Organizational Culture; Quality; Pharmaceutical Industry
Rose, Clayton S., Sandra J. Sucher, Rachel Gordon, and Matthew Preble. "On Weldon's Watch: Recalls at Johnson & Johnson from 2009 to 2010." Harvard Business School Case 311-029, October 2010. (Revised August 2016.)
- June 1993 (Revised April 1998)
- Case
COMCO Holding AG (B): COMCO Martech
COMCO Martech was a new breed of joint venture for COMCO Holding, a mid-sized Swiss-German company that had grown over a five-year period through tie-ups with small, start-up companies. Whereas a typical COMCO venture provided services to a large German retailer, was... View Details
Keywords: Joint Ventures; Business Startups; Trade; Operations; Environmental Sustainability; Business or Company Management; Multinational Firms and Management; Partners and Partnerships; Switzerland; United States; Europe
Kanter, Rosabeth M. "COMCO Holding AG (B): COMCO Martech." Harvard Business School Case 393-143, June 1993. (Revised April 1998.)
- 08 Dec 2009
- First Look
First Look: Dec. 8
argues, the political context of semi-colonialism and imperialism in the first half of the 20th century framed the emergence and growth of railroad companies in China. This is not to say that individual railroad lines were not able to... View Details
Keywords: Martha Lagace
- 23 Aug 2016
- First Look
August 23, 2016
methods. Myth Number 1: Environmental, social, and governance (ESG) programs reduce returns on capital and long-run shareholder value. Reality: Companies committed to ESG are finding competitive advantages in product, labor, and capital... View Details
Keywords: Sean Silverthorne
- April 2022
- Teaching Note
CVS Health: Prescription for Transformation
By: Rosabeth Moss Kanter and Catarina Martinez
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant). The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a... View Details
Keywords: Health; COVID-19 Pandemic; Primary Care; Leadership; Change Management; Women Executives; Retail; Pharmacy; Pharmacy Benefit Manager; Clinical Trials; Vaccination; Acquisition; Innovation and Invention; Transformation; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
had from such a historical understanding of political economy and of power in an economic age. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=53309 forthcoming Encyclopedia of International Economics and Global Trade, Vol. 3: Foreign Direct Investment... View Details
Keywords: Sean Silverthorne
- 31 May 2011
- First Look
First Look: May 31
research on admired companies from four continents, followed in over 20 countries, to derive six propositions about the role of humanistic institutional logic. Download the paper: http://www.hbs.edu/research/pdf/11-119.pdf Cases &... View Details
Keywords: Sean Silverthorne
- 07 Mar 2017
- First Look
First Look at New Research, March 7
is a Peruvian grower, exporter, and marketer of fruits and vegetables, with a focus on the high-growth, high-margin blueberry category. Camposol aspires to become Peru’s first multinational branded produce company. It already has a strong... View Details
Keywords: Sean Silverthorne
- 07 May 2013
- First Look
First Look: May 7
their own business and balancing the demands between their work and family obligations while creating a company that was responsive to their employees' and their customers' needs. The Bursteins had joined a large View Details
Keywords: Carmen Nobel
- 28 Apr 2010
- Research & Ideas
Earth Day Reflections
opportunity to engage in a virtual dialogue on these matters. Some major corporations are starting to take the lead in this effort, including United Technologies Corporation, Philips (the Dutch electronics and health care giant), the German chemical View Details
Keywords: by Staff
- 28 Jul 2008
- Research & Ideas
Making the Decision to Franchise (or not)
appears to be true when you get a new type of consumer for the same product." In the pharmaceutical industry, for example, selling medicine to both an independent general practitioner and a hospital will require a different organizational... View Details
- August 1997 (Revised March 1998)
- Case
Unilever's Butter-Beater: Innovation for Global Diversity
By: Clayton M. Christensen and Jorg Zobel
Unilever, one of the world's largest food product manufacturers, has achieved impressive growth in Europe, primarily by acquiring local food companies. Initially Unilever allowed each acquired company to manage its own product development in a way that was tailored to... View Details
Keywords: Growth Management; Brands and Branding; Product Development; Mergers and Acquisitions; Local Range; Cross-Cultural and Cross-Border Issues; Marketing Strategy; Multinational Firms and Management; Innovation and Management; Food; Conflict Management; Food and Beverage Industry; Manufacturing Industry; Europe
Christensen, Clayton M., and Jorg Zobel. "Unilever's Butter-Beater: Innovation for Global Diversity." Harvard Business School Case 698-017, August 1997. (Revised March 1998.)
- November 2023 (Revised April 2024)
- Case
BiomX: Bringing Phage Back to the Stage
By: Paul A. Gompers, Elie Ofek, Orna Dan and Emilie Billaud
In the spring of 2023, and following the favorable results of a trial involving its phage cocktail for treating lung infections among cystic fibrosis (CF) patients, the leadership of BiomX had several critical issues to wrestle with. First, given its precarious... View Details
Keywords: Working Capital; Financing and Loans; Health Testing and Trials; Product Development; Research and Development; Science-Based Business; Commercialization; Pharmaceutical Industry; Pharmaceutical Industry
Gompers, Paul A., Elie Ofek, Orna Dan, and Emilie Billaud. "BiomX: Bringing Phage Back to the Stage." Harvard Business School Case 524-051, November 2023. (Revised April 2024.)
- 22 Aug 2022
- Research & Ideas
Can Amazon Remake Health Care?
need to do these [things] because we know patients respond to these financial barriers by cutting back on valuable care. Amazon’s not going to fix that problem. Amazon is good at selling other people’s products—but I don’t see it as a View Details
- June 2012
- Case
GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships
By: Arthur A. Daemmrich and Ian McKown Cornell
Three years into a major public-private partnership between GlaxoSmithKline and Fiocuz, Brazil's principal health institute, the company assesses technology transfer and joint research under the agreement. GSK was selling its Synflorix vaccine (against pediatric... View Details
Keywords: Public-Private Partnerships; Business and Government Relations; Foreign Direct Investment; Health Care and Treatment; Globalized Firms and Management; Pharmaceutical Industry; Pharmaceutical Industry; Brazil
Daemmrich, Arthur A., and Ian McKown Cornell. "GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships." Harvard Business School Case 712-049, June 2012.